Luca Capocci

459 total citations
20 papers, 348 citations indexed

About

Luca Capocci is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cell Biology. According to data from OpenAlex, Luca Capocci has authored 20 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 5 papers in Cell Biology. Recurrent topics in Luca Capocci's work include Genetic Neurodegenerative Diseases (11 papers), Mitochondrial Function and Pathology (8 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Luca Capocci is often cited by papers focused on Genetic Neurodegenerative Diseases (11 papers), Mitochondrial Function and Pathology (8 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Luca Capocci collaborates with scholars based in Italy, Germany and United States. Luca Capocci's co-authors include Alba Di Pardo, Vittorio Maglione, Salvatore Castaldo, Giuseppe Pepe, Enrico Amico, Michele Madonna, Federico Marracino, Stefania Crispi, Francesca Elifani and Stefania Filosa and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Human Molecular Genetics.

In The Last Decade

Luca Capocci

19 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luca Capocci Italy	10	208	113	64	56	52	20	348
Dove Keith United States	7	200 1.0×	169 1.5×	32 0.5×	57 1.0×	67 1.3×	10	418
Alejandro O. Sodero Argentina	10	211 1.0×	124 1.1×	43 0.7×	31 0.6×	88 1.7×	16	384
Laura López-Molina Spain	6	167 0.8×	135 1.2×	82 1.3×	33 0.6×	126 2.4×	8	343
Jiabin Tong China	10	119 0.6×	102 0.9×	107 1.7×	26 0.5×	39 0.8×	15	358
Angela M. Brennan‐Minnella United States	8	217 1.0×	133 1.2×	88 1.4×	19 0.3×	52 1.0×	9	381
Dhruba Pathak United States	9	303 1.5×	109 1.0×	123 1.9×	25 0.4×	112 2.2×	17	562
Joshua Park United States	10	170 0.8×	87 0.8×	27 0.4×	51 0.9×	78 1.5×	14	389
Jeha Jeon South Korea	10	267 1.3×	138 1.2×	133 2.1×	30 0.5×	101 1.9×	12	531
Danying Yang China	8	170 0.8×	46 0.4×	68 1.1×	23 0.4×	88 1.7×	9	356
Sunitha Rangaraju United States	11	207 1.0×	149 1.3×	44 0.7×	57 1.0×	117 2.3×	14	526

Countries citing papers authored by Luca Capocci

Since Specialization

Citations

This map shows the geographic impact of Luca Capocci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Capocci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Capocci more than expected).

Fields of papers citing papers by Luca Capocci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Capocci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Capocci. The network helps show where Luca Capocci may publish in the future.

Co-authorship network of co-authors of Luca Capocci

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Capocci. A scholar is included among the top collaborators of Luca Capocci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Capocci. Luca Capocci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Pepe, Giuseppe, Paola Lenzi, Luca Capocci, et al.. (2023). Treatment with the Glycosphingolipid Modulator THI Rescues Myelin Integrity in the Striatum of R6/2 HD Mice. International Journal of Molecular Sciences. 24(6). 5956–5956. 1 indexed citations

2.

Pepe, Giuseppe, Maria Cotugno, Federico Marracino, et al.. (2023). Abnormal expression of sphingolipid-metabolizing enzymes in the heart of spontaneously hypertensive rat models. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1869(1). 159411–159411. 3 indexed citations

3.

Pepe, Giuseppe, Salvatore Fioriniello, Federico Marracino, et al.. (2023). Blood–Brain Barrier Integrity Is Perturbed in a Mecp2-Null Mouse Model of Rett Syndrome. Biomolecules. 13(4). 606–606. 9 indexed citations

4.

Pepe, Giuseppe, Luca Capocci, Federico Marracino, et al.. (2022). Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s disease. Molecular Therapy. 31(1). 282–299. 12 indexed citations

5.

Rosa, Paolo, Giuseppe Pepe, Giorgio Mangino, et al.. (2022). Polysialic Acid Sustains the Hypoxia-Induced Migration and Undifferentiated State of Human Glioblastoma Cells. International Journal of Molecular Sciences. 23(17). 9563–9563. 12 indexed citations

6.

Pepe, Giuseppe, Luca Capocci, Federico Marracino, et al.. (2022). I18 Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase (SGPL1), modulates glycosphingolipid metabolism and results therapeutically effective in a mouse model of Huntington’s disease. 1 indexed citations

7.

Burtscher, Johannes, Giuseppe Pepe, Federico Marracino, et al.. (2021). Brain Region and Cell Compartment Dependent Regulation of Electron Transport System Components in Huntington’s Disease Model Mice. Brain Sciences. 11(10). 1267–1267.

8.

Pepe, Giuseppe, Maria Cotugno, Federico Marracino, et al.. (2021). Differential Expression of Sphingolipid Metabolizing Enzymes in Spontaneously Hypertensive Rats: A Possible Substrate for Susceptibility to Brain and Kidney Damage. International Journal of Molecular Sciences. 22(7). 3796–3796. 9 indexed citations

9.

Pardo, Alba Di, Giuseppe Pepe, Luca Capocci, et al.. (2020). Treatment with K6PC-5, a selective stimulator of SPHK1, ameliorates intestinal homeostasis in an animal model of Huntington's disease. Neurobiology of Disease. 143. 105009–105009. 9 indexed citations

10.

Pardo, Alba Di, Giuseppe Pepe, Salvatore Castaldo, et al.. (2019). Stimulation of Sphingosine Kinase 1 (SPHK1) Is Beneficial in a Huntington’s Disease Pre-clinical Model. Frontiers in Molecular Neuroscience. 12. 100–100. 31 indexed citations

11.

Elifani, Francesca, Enrico Amico, Giuseppe Pepe, et al.. (2019). Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington’s disease.. Human Molecular Genetics. 40 indexed citations

12.

Pardo, Alba Di, Salvatore Castaldo, Enrico Amico, et al.. (2018). Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood–brain barrier integrity and exerts therapeutic effect in an animal model of Huntington’s disease. Human Molecular Genetics. 27(14). 2490–2501. 41 indexed citations

13.

Pepe, Giuseppe, Enrico Amico, Salvatore Castaldo, et al.. (2018). A25 Metabolism of sialo-conjugates is defective in pre-clinical models of huntington’s disease. Radboud Repository (Radboud University). A9.1–A9. 5 indexed citations

14.

Pardo, Alba Di, Salvatore Castaldo, Luca Capocci, Enrico Amico, & Vittorio Maglione. (2017). Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease. Journal of Visualized Experiments. 13 indexed citations

15.

Pardo, Alba Di, Enrico Amico, Francesco Scalabrì, et al.. (2017). Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease. Scientific Reports. 7(1). 41316–41316. 82 indexed citations

16.

Pardo, Alba Di, Albino Carrizzo, Antonio Damato, et al.. (2017). Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington’s disease transgenic R6/2 (160 CAG) mice. Scientific Reports. 7(1). 42797–42797. 3 indexed citations

17.

Fazio, Francesco, Albino Carrizzo, Luana Lionetto, et al.. (2017). Vasorelaxing Action of the Kynurenine Metabolite, Xanthurenic Acid: The Missing Link in Endotoxin-Induced Hypotension?. Frontiers in Pharmacology. 8. 214–214. 33 indexed citations

18.

Pardo, Alba Di, Salvatore Castaldo, Luca Capocci, Enrico Amico, & Vittorio Maglione. (2017). Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease. Journal of Visualized Experiments. 6 indexed citations

19.

Elifani, Francesca, Stefania Crispi, Stefania Filosa, et al.. (2016). L9 Curcumin: a natural compound to counteract the pathology of huntington’s disease?. Journal of Neurology Neurosurgery & Psychiatry. 87(Suppl 1). A93.1–A93. 5 indexed citations

20.

Carrizzo, Albino, Mariateresa Ambrosio, Antonio Damato, et al.. (2016). Morus alba extract modulates blood pressure homeostasis through eNOS signaling. Molecular Nutrition & Food Research. 60(10). 2304–2311. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact